← Back to all trials
Completed
NCT06546410
OASIS: RetrOspective Analysis on EEGs for Identifying Seizure Susceptibility in paediatrIcs Using biomarkerS
Conditions: Epilepsy, Epilepsy in Children
Sex: All
Ages: 2 Years – 18 Years
Enrollment: 530
Sponsor: Neuronostics Ltd
Location: Alder Hey Children's NHS Foundation Trust Liverpool
Summary
The goal of this retrospective study is to validate a set of computational biomarkers (BioEP) for seizure susceptibility on retrospective routinely collected non-contributory EEGs in paediatric participants with epilepsy. The main objectives are:
Primary:
To validate a set of computational biomarkers (BioEP) for seizure susceptibility on retrospective routinely collected non-contributory EEGs in paediatric participants with epilepsy.
Secondary:
To examine whether the use of BioEP could support a more efficient patient pathway to diagnosis (thus adding economic value), by reducing time to final diagnosis and/or the number of clinical appointments needed
Eligibility Criteria
Inclusion Criteria:
* ≥2-\
Source: ClinicalTrials.gov (NCT06546410). StuddyBuddy aggregates publicly available trial information.
